These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 12883080)
1. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the regulation and posttranslational modification of p27kip1 in lipopolysaccharide-activated B cells. Crawford RB; Sulentic CE; Yoo BS; Kaminski NE Toxicol Sci; 2003 Oct; 75(2):333-42. PubMed ID: 12883080 [TBL] [Abstract][Full Text] [Related]
2. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the regulation of Pax5 in lipopolysaccharide-activated B cells. Yoo BS; Boverhof DR; Shnaider D; Crawford RB; Zacharewski TR; Kaminski NE Toxicol Sci; 2004 Feb; 77(2):272-9. PubMed ID: 14600275 [TBL] [Abstract][Full Text] [Related]
3. Aryl hydrocarbon receptor-dependent inhibition of AP-1 activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin in activated B cells. Suh J; Jeon YJ; Kim HM; Kang JS; Kaminski NE; Yang KH Toxicol Appl Pharmacol; 2002 Jun; 181(2):116-23. PubMed ID: 12051995 [TBL] [Abstract][Full Text] [Related]
4. Aryl hydrocarbon receptor-dependent suppression by 2,3,7, 8-tetrachlorodibenzo-p-dioxin of IgM secretion in activated B cells. Sulentic CE; Holsapple MP; Kaminski NE Mol Pharmacol; 1998 Apr; 53(4):623-9. PubMed ID: 9547351 [TBL] [Abstract][Full Text] [Related]
5. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated impairment of B cell differentiation involves dysregulation of paired box 5 (Pax5) isoform, Pax5a. Schneider D; Manzan MA; Crawford RB; Chen W; Kaminski NE J Pharmacol Exp Ther; 2008 Aug; 326(2):463-74. PubMed ID: 18483191 [TBL] [Abstract][Full Text] [Related]
6. Putative link between transcriptional regulation of IgM expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin and the aryl hydrocarbon receptor/dioxin-responsive enhancer signaling pathway. Sulentic CE; Holsapple MP; Kaminski NE J Pharmacol Exp Ther; 2000 Nov; 295(2):705-16. PubMed ID: 11046109 [TBL] [Abstract][Full Text] [Related]
7. Involvement of Blimp-1 and AP-1 dysregulation in the 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated suppression of the IgM response by B cells. Schneider D; Manzan MA; Yoo BS; Crawford RB; Kaminski N Toxicol Sci; 2009 Apr; 108(2):377-88. PubMed ID: 19237549 [TBL] [Abstract][Full Text] [Related]
8. The AhR and NF-κB/Rel Proteins Mediate the Inhibitory Effect of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin on the 3' Immunoglobulin Heavy Chain Regulatory Region. Salisbury RL; Sulentic CE Toxicol Sci; 2015 Dec; 148(2):443-59. PubMed ID: 26377645 [TBL] [Abstract][Full Text] [Related]
9. 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated suppression of toll-like receptor stimulated B-lymphocyte activation and initiation of plasmacytic differentiation. North CM; Crawford RB; Lu H; Kaminski NE Toxicol Sci; 2010 Jul; 116(1):99-112. PubMed ID: 20348231 [TBL] [Abstract][Full Text] [Related]
11. Selective effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and corticosteroid on in vitro lymphocyte maturation. Luster MI; Germolec DR; Clark G; Wiegand G; Rosenthal GJ J Immunol; 1988 Feb; 140(3):928-35. PubMed ID: 3257509 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of calcium-dependent B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Karras JG; Holsapple MP Toxicol Appl Pharmacol; 1994 Apr; 125(2):264-70. PubMed ID: 8171434 [TBL] [Abstract][Full Text] [Related]
13. 2,3,7,8-Tetrachlorodibenzo-p-dioxin promotes astrocyte activation and the secretion of tumor necrosis factor-α via PKC/SSeCKS-dependent mechanisms. Zhang Y; Nie X; Tao T; Qian W; Jiang S; Jiang J; Li A; Guo A; Xu G; Wu Q J Neurochem; 2014 Jun; 129(5):839-49. PubMed ID: 24673440 [TBL] [Abstract][Full Text] [Related]
14. Suppression of human B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin involves altered regulation of B cell lymphoma-6. Phadnis-Moghe AS; Crawford RB; Kaminski NE Toxicol Sci; 2015 Mar; 144(1):39-50. PubMed ID: 25543051 [TBL] [Abstract][Full Text] [Related]
15. Interactions at a dioxin responsive element (DRE) and an overlapping kappaB site within the hs4 domain of the 3'alpha immunoglobulin heavy chain enhancer. Sulentic CE; Kang JS; Na YJ; Kaminski NE Toxicology; 2004 Aug; 200(2-3):235-46. PubMed ID: 15212819 [TBL] [Abstract][Full Text] [Related]
16. An integrated genomic analysis of aryl hydrocarbon receptor-mediated inhibition of B-cell differentiation. De Abrew KN; Kaminski NE; Thomas RS Toxicol Sci; 2010 Dec; 118(2):454-69. PubMed ID: 20819909 [TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of TCDD-induced AhR-mediated gene expression in human, mouse and rat primary B cells. Kovalova N; Nault R; Crawford R; Zacharewski TR; Kaminski NE Toxicol Appl Pharmacol; 2017 Feb; 316():95-106. PubMed ID: 27913140 [TBL] [Abstract][Full Text] [Related]
18. 2,3,7,8-tetrachlorodibenzo-p-dioxin, an exogenous modulator of the 3'alpha immunoglobulin heavy chain enhancer in the CH12.LX mouse cell line. Sulentic CE; Zhang W; Na YJ; Kaminski NE J Pharmacol Exp Ther; 2004 Apr; 309(1):71-8. PubMed ID: 14718603 [TBL] [Abstract][Full Text] [Related]
19. Induction of apoptosis by 2,3,7,8-tetrachlorodibenzo-p-dioxin following endotoxin exposure. Patterson RM; Stachlewitz R; Germolec D Toxicol Appl Pharmacol; 2003 Jul; 190(2):120-34. PubMed ID: 12878042 [TBL] [Abstract][Full Text] [Related]
20. The expression of membrane and secreted immunoglobulin during the in vitro differentiation of the murine B cell lymphoma CH12. Stockdale AM; Dul JL; Wiest DL; Digel M; Argon Y J Immunol; 1987 Nov; 139(10):3527-35. PubMed ID: 3500220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]